Repurposing the in-house generated Alzheimer’s disease targeting molecules through computational and preliminary in-vitro studies for the management of SARS-coronavirus-2

unknow

★ 5.0 · 33 reads

Request Code

ZLIB.IO18514229

Published

2022

Pages

1

Language

Unknown